Table 3 Correlation of the pathological features and Cyr61 expression positive rate
Pathological type | Cyr61 expression | |||||
|---|---|---|---|---|---|---|
Negative (0) | Weak (1–3) | Moderate (4–7) | Strong (8–12) | Positive rate | ||
Ovarian serous cystadenoma (n = 18) | 9 | 8 | 1 | 0 | 5.56 | |
Ovarian serous adenocarcinoma (n = 66) | G1/G2 (n = 7) | 0 | 3 | 4 | 0 | 57.14** |
G3 (n = 59) | 0 | 6 | 38 | 15 | 89.83** | |
Paired Metastatic site (n = 20) | 0 | 0 | 1 | 19 | 95.00* | |